Connect with us

BUSINESS

Tilray (TLRY) Joins Cannabis Sector’s Pause, Which Is Good News For People Who Missed Its July IPO

Published

on

With the high-flying cannabis sector taking a pause, now is the time for investors to reassess their positions.

A good place to start would be by taking a moment to examine who is guiding cannabis-focused companies. In other words, who is it that is forming a company’s reputation.

Take, for example, high-flying Tilray, Inc. (TLRY). It’s a pioneer in medical cannabis research, cultivation, processing, and distribution. Now it is rapidly staking a strong place in Canada’s soon-to-be legal adult marijuana market.

Looking beyond its world-class research teams, investors will discover Tilray has one of the sector’s most prestigious board of directors.

Tilray’s board includes Rebekah Doop, who is a principal at Google. Then there’s Scotty Greenwood, who was chief of staff sat the U.S. Embassy in Canada, and is now the CEO of the Canadian American Business Council.

Of course, the board itself is not solely responsible for the 400 percent run up since Tilray’s July IPO. Still, it should comfort investors to know Tilray is in such good hands.

Doop and Greenwood are joined on the board by other corporate heavyweights, such as Christine St. Claire, who was a principal and lead audit partner at KPMG; Michael Auerbach, a risk expert who has held senior positions at the Center for American Progress and The Century Foundation, where he concentrated on issues related to U.S. Foreign Policy, National Security, and Conflict Resolution.

Rapid Expansion Into Legalized Pot

Based in British Columbia, Canada, Tilray is global concern. It is the only GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments, and researchers in 11 countries on five continents.

It’s also perfectly positioned in the heart of Canada’s legalized cannabis industry.

The Prince Edward Island Cannabis Management Corporation recently selected a Tilray subsidiary to supply its adult-use cannabis.

The purchase order will allow its wholly owned affiliate, The High Park Company, to supply PEI’s four cannabis stores and online channels with cannabis products. It’s all in anticipation of the launch of the adult-use market on October 17, 2018.

In all, Tilray has signed agreements to supply adult-use cannabis to consumers in seven Canadian provinces and territories, including British Columbia, Manitoba, Nova Scotia, Ontario, Quebec, the Yukon territory, and the Northwest Territories

Its subsidiary, High Park, is Toronto-based, and is led by a team with deep experience in cannabis and global consumer brands.

Tilray established High Park in order to develop, sell, and distribute a broad-based portfolio of adult-use cannabis brands and products. Its portfolio is uniquely crafted and grown by master horticulturists dedicated to sustainable growing practices.

Tilray’s shares were downgraded Northland Capital, which gave “complex valuations” as the basis of its esoteric reasoning. Tilray’s share price shed nearly 11 percent on the news.

But Tilray is a strong company.

It has a partnership to develop medical products with Sandoz Canada, a division of Novartis (NVS). Tilray also has a relationship with Privateer Holdings and marijuana information website Leafly, along with distribution deals with Shoppers Drug Mart, Pharmasave and various Canadian provinces.
It is perfectly posi

Continue Reading
Advertisement

BUSINESS

Medmen Enterprises Inc (OTCMKTS:MMNFF) Collaborates With Kikoko, Barkley, And Papa To Promote Its Cannabis Products

Published

on

Medmen Enterprises Inc (OTCMKTS:MMNFF) has collaborated with Kikoko, Barkley, and Papa to promote its cannabis products. They will provide the samples of cannabis products to the Los Angeles Studios such as Cycle House, Oraya Movement, Box Union Robertson, LIT Method, and Sweat Yoga. The visitors to these studios will also benefit from incentives.

Sweat yoga locations

The hot yoga studio – Sweat Yoga operates from locations such as Little Tokyo, Playa Vista Westlake Village, and Santa Monica. It will establish a partnership with Medmen for its Sunday night Yin at all these locations in February and January 2020. Those who attend the classes will have a chance to enjoy samples of Positivi Tea from Kikoko. Barkley and Papa will also distribute the samples of Releaf balm to the attendees.

Cycle House in West Hollywood

Los Angeles premiere indoor cycle studio – Cycle House is situated in West Hollywood. It will partner with Medmen for two rides this month. The attendees will get the samples of Releaf Balm from Barkley and Papa.

Oraya Movement in West Hollywood

The West Hollywood based Oraya Movement will unveil Yoga Workshop, Pilates, and Breathwork on January 19, 2020. The participants will receive the samples of Positivi Tea from Kikoko.

LIT Method – West Hollywood

The West Hollywood based wellness studio – LIT Method will get the sponsorship from Medmen for its two signature classes on January 19, and 12 2020. The participants will receive branded yoga mats and enjoy the samples of Positivi Tea from Kikoko.

Box Union – Robertson Blvd Location

Medmen will partner with Box Union for a Saturday morning class, which will feature top-notch instructors – Justin and Tara, January 25, and 11, 2020. The participants at Robertson Blvd Location will receive samples of Releaf Balm from Barkley and Papa.

The visitors can enjoy hours of comfort in all-natural and rich Botanical Balms, which comprises unmatched terpene content. Positiv Tea from Kikoko is an organically grown and ready to brew green tea with peppermint flavor and blended with Kikogold cannabis active.

All of this is part of Medmen’s “New Year New You” program to allow community engagement this year.

Financial arrangements

Medmen announced several financial arrangements that include the financing of $37 million, cost-cutting measures, and amending outstanding debt to strengthen its balance sheet and improve corporate governance.

Continue Reading

BUSINESS

Kannaway, A Subsidiary Of Medical Marijuana Inc (OTCMKTS:MJNA), Is The Most Popular CBD MLM Company: Hemp Meds Mexico Inaugurates a New Office In Mexico

Published

on

Kannaway, a subsidiary of Medical Marijuana Inc (OTCMKTS:MJNA), has become the well known CBD MLM company in 2020. It finds a place in the HealthMJ’s list this year. Business for Home has listed Kannaway, one of the top hundred MLM companies in 2020.

Kannaway establishes quality standards

Blake Schroeder, Chief Executive Officer of Kannaway, said it is exciting to get recognition as a top player in the industry even today after becoming the first company to market the CBD products in 2014 directly. The enactment of a Farm Bill in 2018 helped the CBD industry to post remarkable growth in 2019. Kannaway played a vital role in 2019 in establishing several safety and quality standards for the market to flourish.

The US consumers learn about CBD from friends

Over 50% of the US consumers learned about cannabidiol for the first time from family and friends. The demand for hemp-based CBD in the US is expected to reach up to $2.75 billion in 2020. According to Direct Selling News, the sales of CBD related products by the direct selling companies are estimated at more than $300 million in 2018.

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, said Kannaway is flourishing in the CBD market, which is growing at a fast pace. He further said the company is excited to get honored on HealthMJ’s list and among the top 100 MLM companies in 2020. The company also bagged several accolades that include BIG Awards for Business, Stevie Awards, and Golden Bridge Awards. It is yearning to receive more such awards this year.

HempMeds Mexico inaugurates new office

HempMeds Mexico, a subsidiary of Medical Marijuana, has inaugurated a new office in Mexico City. President of HempMeds Mexico, Raul Elizalde, said the company is pleased to establish a new office, and it helps to strengthen its footprint in the nation. It is already managing offices in Monterrey since 2017. The newly opened office will help the public with a plethora of information on CBD products being offered in Mexico.

The market for the medical cannabis market

The market for medical cannabis in Mexico in 2018 is estimated at $47.3 million. If cannabis for recreational and medical uses is legalized, the combined demand for medical and recreational use will reach over $1 billion by the year 2024.

Continue Reading

BUSINESS

Sundial Growers Inc (NASDAQ:SNDL) And Vir Biotechnology Inc (NASDAQ:VIR) Strike Deal To Support Clinical Studies

Published

on

Sundial Growers Inc (NASDAQ:SNDL) and Vir Biotechnology Inc (NASDAQ:VIR) are into a new deal that spans about three years. The terms of the deal outline that Sundial will be serving Vir Pharma with medical cannabis oil supplies.

The business cooperation

On the other hand, Vir Pharma intends to make an impact in the treatment of chronic pain and will be using products from the business partner. The plan is to conduct its clinical studies effectively in Australia, and the oral formulations will be used in the development of its prescription drug.

The proprietary drug will be developed using cannabis products, and the company is optimistic patients will benefit from the medication. It will be about giving them a break from the use of the various treatments developed using opioids.

Thoughts from leaders

The Chief Operating Officer of Sundial, known as Brian Harriman, is one of the leaders that have spoken concerning the matter. The official has termed the recent move an outstanding one considering that it is about them triumphant entry into Australia. It also marks the company’s first global exports, and the official believes that they are taking steps in the right direction.

The leader also thinks quite highly about their business partner calling it one of the leading companies in the market. He believes that it is such a great honor getting the opportunity to work with Vir Pharma on their quest to grasp business leadership. Harriman also says that the patients in Australia deserve the best form of treatment, and it is a good thing that they will be receiving the top quality cannabis-based therapies.

The terms of this deal also provide that the cannabis blend developed by the two will be marketed under Vir Pharma’s label, and the brand name will be Virabis.

The CEO of Vir Pharma Joel Hardy has also spoken on behalf of his company, outlining that they are proud to be a part of the companies focusing on developing cannabis medicines. According to him, these full-spectrum medicines are essential in helping to eliminate or minimize the use of opioid products as a form of treatment. He says that he will be at the frontline in supporting the cooperation between the two companies.

Continue Reading



Trending Stories